Pharmaceutical

Sonnet BioTherapeutics secures US patent covering two drug candidates

Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 and SON-1400, expected to advance treatment options for cancer.

Nov 9, 2024 - 06:00
Sonnet BioTherapeutics secures US patent covering two drug candidates
Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 and SON-1400, expected to advance treatment options for cancer.
Read the original article

Tags:

Previous Article

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

Next Article

Santen, Arctic Vision sign deal for ARVN001 to treat UME

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: ‘No data more personal’: Patients, digital health players weigh in on the FTC’s data privacy plan

STAT+: ‘No data more personal’: Patients, digital healt...

Aug 9, 2023

EC grants orphan medicinal product status to Rocket’s RP-A601

EC grants orphan medicinal product status to Rocket’s R...

May 31, 2024

STAT+: Eli Lilly, riding a hot streak, expects to double planned employment in Boston research center

STAT+: Eli Lilly, riding a hot streak, expects to doubl...

Oct 20, 2023